The tumor suppressor CDX2 opposes pro-metastatic biomechanical modifications of colon cancer cells through organization of the actin cytoskeleton-Reference-Cited by-同舟云学术

The tumor suppressor CDX2 opposes pro-metastatic biomechanical modifications of colon cancer cells through organization of the actin cytoskeleton

Published:2017-02 Issue: Volume:386 Page:57-64
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Platet Nadine,Hinkel Isabelle,Richert Ludovic,Murdamoothoo Devadarssen,Moufok-Sadoun Ahlam,Vanier Marie,Lavalle Philippe,Gaiddon Christian,Vautier Dominique,Freund Jean-Noel,Gross Isabelle

Funder

INSERM

CNRS

Institut National du Cancer

La Ligue contre le Cancer

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

2. The physics of cancer: the role of physical interactions and mechanical forces in metastasis;Wirtz;Nat. Rev. Cancer,2011

3. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits;Polyak;Nat. Rev. Cancer,2009

4. Frequent rearrangements and amplification of the CDX2 homeobox gene in human sporadic colorectal cancers with chromosomal instability;Subtil;Cancer Lett.,2007

5. Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumor environment in malignant tumor progression;Brabletz;Cancer Res.,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of Cytotoxic Iron‐Containing Macrocycles Through Unexpected C(sp²)−C(sp²) Bonds Formation;European Journal of Inorganic Chemistry;2023-05-09

2. CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors;Scientific Reports;2023-03-16

3. Scanning Capillary Microscopy in the Study of the Effect of Cytotoxic Agents on the Biomechanical and Physicochemical Properties of Tumor Cells;Pharmaceutical Chemistry Journal;2022-12

4. CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer;Disease Markers;2022-10-12

5. CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors;2022-09-21